JERUSALEM -- (Marketwired) -- 06/21/13 -- IDenta Corp. (OTC Pink: IDTA) CEO Yaacov Shoham released today the last Media Placement at Examiner.com:
Examiner.com (with 10.387.374 unique monthly visitors) featured a review of the Identa - Touch and Know kit.
Examiner.com provides hyper localized content and serves as a daily news and entertainment hub comprised of several regional editions.
Marketed under the brand name Touch&Know, the over-the-counter unit combines safety, accuracy, affordability and ease of use for the consumer. The kit, based on proven field tests used extensively by law enforcement worldwide, is based on technology which is now available to the general public for the first time ever.
"Touch&Know is the first non-biological drug testing kit offered by a US retailer," explained Shoham. "Touch&Know safely tests the substance, as opposed to the person, and provides immediate results. It is a fully non-invasive method. We are proud to have partnered with the drug store chain, the largest retail pharmacy chain in America, to make this product available to all consumers." The drug store chain operates more than 8600 outlets in all 50 US states.
Touch&Know contains two detectors: one for general screening and one for marijuana/hashish. The patented retail package is able to detect 22 different kinds of illegal drugs.
The testing kit provides immediate display of results without lab involvement, ensuring a 99% accuracy rate in results -- environmentally friendly and in a non-confrontational approach requiring no bodily fluids.
IDenta Corp. is committed to the belief that any effective anti-drug policy begins with the ability to quickly gather credible evidence. Touch&Know offers the means to do so. The detector can assist with the resolution of drug-related issues in the home, schools and businesses.
For interviews and additional information, please contact:
Oximeter Plus, Inc.
516 626-6226 Ext 300
Operating since 2003, IDenta Corporation (www.touchandknow.net, www.identa-corp.com) has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and consumer markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies worldwide. Additional information may be accessed at www.drugsdetector.com, and www.identa.biz.
Certain statements contained herein may be, within the meaning of the Federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors,
Most Popular Stories
- Top Hispanic Tech Companies Push for the Top
- 5 Notable Hispanic Technology Executives
- California Establishes Center for Coffee Study
- FAA to Appeal Court Decision Allowing Commercial Drone Use
- Tesla's Alt-Energy Future Aims for Massive Lithium-Ion Battery Production
- Spotify Picking up Echo Nest
- Social Media Can Help a Company's Credit Line
- Lawful Immigrants Defend Driver's Licenses
- Taco Bell Rings Up Breakfast Menu
- New Chat App, Yik Yak, Causes Problems for Students